Exodus Point Capital Management, LP Castle Biosciences Inc Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$18.76 - $32.72 $1.24 Million - $2.16 Million	66,079 Added 575.4%	77,563 $1.55 Million
Q4 2024 Feb 12, 2025	SELL	$26.52 - $34.67 $869,299 - $1.14 Million	-32,779 Reduced 74.06%	11,484 $306,000
Q3 2024 Nov 12, 2024	BUY	$17.4 - $31.47 $71,827 - $129,908	4,128 Added 10.29%	44,263 $1.26 Million
Q2 2024 Aug 13, 2024	BUY	$18.84 - $24.94 $756,143 - $1 Million	40,135 New	40,135 $874,000
Q2 2023 Aug 10, 2023	BUY	$11.66 - $26.0 $481,464 - $1.07 Million	41,292 Added 183.68%	63,773 $875,000
Q1 2023 May 11, 2023	BUY	$19.47 - $28.49 $437,705 - $640,483	22,481 New	22,481 $511,000
Q3 2020 Nov 16, 2020	SELL	$38.47 - $52.03 $225,318 - $304,739	-5,857 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $159,778 - $251,909	5,857 New	5,857 $221,000

170

27.9M

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $637M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.